Search results
Can Lowering Your Blood Pressure Prevent Uterine Fibroids? Doctors Cast Doubt on New Study
Verywell Health· 2 hours agoA new study indicates that lowering blood pressure could be related to uterine fibroids, but small...
Pigment Dispersion Syndrome
Verywell Health· 3 hours agoPigment dispersion syndrome occurs when increased amounts of pigment, or the material that gives your iris its color, circulate freely in the eye. Learn...
Up to 70% of People With Asthma and COPD Go Undiagnosed
The New York Times· 6 hours agoThe question caught her attention: Just a week earlier, Hein, then 24, had gone on a stroll with her...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health· 6 hours ago(ustekinumab), which required only one shot every three months with the same effect. After a decade...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive· 6 hours agoA third bispecific antibody, code-named AZD0486, simultaneously binds certain proteins on immune and...
How to Have Great Sex If You Deal With Chronic Pain
Self· 6 hours agoManagement: Strategies for Integrated Treatment, tells SELF. Antidepressants, anxiolytics (anxiety meds), and some muscle...
'Unusual' form of cell death underlies lung damage in Covid patients: Study
Business Standard India· 7 hours agoAn unusual form of cell death could lead to a Covid patient's lungs suffering extreme damage,...
Leg Pain: Potential Causes and How to Find Relief At Home
Verywell Health· 7 hours agoInjury to the muscles, bones, and nerves, or an underlying condition, can all cause leg pain. Here’s...
Dr Reddy's, Alvotech ink licencing pact for commercialising denosumab biosimilar | Hyderabad News -...
The Times of India· 7 hours agoATV03 is a biosimilar candidate to Prolia and Xgeva that are used for the treatment of diseases such...
Glenmark to commercialise BeiGene’s oncology drugs in India
The Hindu· 7 hours agoDrugmaker Glenmark has entered into an exclusive marketing and distribution agreement with BeiGene to register and commercialise the latter’s oncology medicines ...
